Neutropenia with ticlopidine plus aspirin

Lancet

Volumn 349, Issue 9050, 1997, Pages 474-475

  Haushofer, Alexander ^a   Halbmayer, Walter Michael ^b   Prachar, Herbert ^b  

^a Municipal Hospital Lainz   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TICLOPIDINE;

AGRANULOCYTOSIS; ARTICLE; BLOOD CELL COUNT; CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; DIARRHEA; DRUG MONITORING; HEMATOMA; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; NAUSEA; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; RASH; STENT;

EID: 0031050657     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)61186-5     Document Type: Article

References (5)

1. Schömig A, Neumann F-J, Kastrati A. A randomised comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334: 1084-89.
2. Hass WK, Easton JD, Adams HP Jr, et al. A randomised trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321: 501-07.
3. Ticlopidine Aspirin Stroke Study Group. Ticlopidine versus aspirin for stroke prevention: on-treatment results from the Ticlopidine Aspirin Stroke Study. J Stroke Cerebrovasc Dis 1993; 3: 168-76.
4. Gent M, Blakely JA, Easton JD, et al.The Canadian American Ticlopidine Study (CATS) in thromboembolic stoke. Lancet 1989; i: 1215-20.
5. Shear NH, Appel C. Prevention of ischemic stroke. N Engl J Med 1995; 333: 460.